comparemela.com

Latest Breaking News On - Head of preclinical sciences - Page 1 : comparemela.com

Charm Therapeutics: CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI technology

Investegate |Charm Therapeutics Announcements | Charm Therapeutics: CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI technology

Investegate announcements from Charm Therapeutics, CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI technology

Vor to Present New Platform and Preclinical Data at ASH

Dr Rebecca Wong named among Stanford University s list of World s Top 2% scientists

Dr Rebecca Wong named among Stanford University’s list of World’s Top 2% scientists 25 Feb 2021 / 13:47 H. Dr Rebecca Wong -SEGi University and Colleges KOTA DAMANSARA, Feb 25: Dr. Rebecca Wong Shin Yee, Associate Professor of Physiology and Head of Preclinical Sciences at SEGi University’s Faculty of Medicine have been listed among the World’s Top 2% Scientists by Stanford University published in October 2020. The list represents the top 2% of the world’s most-cited scientists in various disciplines.(Source: https://doi.org/10.1371/journal.pbio.3000918 ; https://data.mendeley.com/datasets/btchxktzyw/2) “SEGi is honoured to have one of our esteemed academics listed among the World’s Top 2% Scientists by Stanford University. Dr. Rebecca Wong’s achievements have set a high standard for our faculties to follow. Our heartiest congratulations to Dr. Rebecca Wong,” said Ms Hew Moi Lan, Group Executive Director and Group Chief Executive Officer of SEG Internation

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.